Bunge Global S.A. (BG) Stock Analysis
Is BG a good investment?
Bunge Global S.A. (BG) has a Plutrex AI rating of 62.5/100 as of August 21, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: 5-Year Forward EPS Growth of 17.0% is 103.8% above the industry average of 8.36%, making BG the sector's long-term earnings growth leader — and yet it trades at a 35.6% PEG discount (0.61 vs. 0.947 industry average), creating a compelling relative value opportunity for patient investors. Main concern: Deeply negative free cash flow of -$6.475B is the single most critical risk — this means BG is consuming cash at a massive rate, and the $600M senior notes offering (headline: 'Bunge Global SA Announces Pricing of $600 Million Senior Notes Offering') confirms the company is funding itself with debt; with only $788M cash on hand, if FCF does not normalize, the balance sheet will deteriorate rapidly and dividend/buyback sustainability is questionable.
Investment Summary
Bunge Global (BG) is a structurally low-margin agribusiness trading at a meaningful discount to both its growth potential and its peer group, but burdened by deeply negative free cash flow (-$6.475B) that fundamentally undermines the earnings-based investment case. The stock trades at $116.57 against an analyst consensus target of $144.20 (23.7% implied upside). The PEG ratio of 0.61 versus the industry average of 0.947 makes BG the most attractively priced stock on a growth-adjusted basis in its peer group. The PE of 22.6x is 14.8% below the industry average of 26.53x despite BG's 5-year forward EPS growth of 17.0% being more than double the industry average of 8.36%. However, the net margin of 1.1% (vs. industry 3.18%), gross margin of 4.87% (vs. industry 11.58%), and ROE of 7.5% (below my 15% threshold) reflect a structurally thin-margin commodity business. The Viterra acquisition integration is driving near-term growth (Q2 2026 results showed soybean and softseed processing strength), but the $600M senior notes offering signals continued capital needs. This is a HOLD/SPECULATIVE BUY for patient investors who believe FCF will normalize and EPS projections will materialize — not a high-conviction buy given the cash burn.
Key Strengths
- 5-Year Forward EPS Growth of 17.0% is 103.8% above the industry average of 8.36%, making BG the sector's long-term earnings growth leader — and yet it trades at a 35.6% PEG discount (0.61 vs. 0.947 industry average), creating a compelling relative value opportunity for patient investors
- Viterra acquisition integration is delivering tangible results: Q2 2026 earnings showed soybean and softseed processing segment strength, with adjusted EPS jumping significantly year-over-year, validating the strategic rationale for the deal and providing a credible catalyst for the 17% forward EPS growth projections
- Valuation discount is multi-dimensional: PE of 22.6x is 14.8% below peers, PEG of 0.61 is 35.6% below peers, and P/B of 1.40x provides asset-level downside protection — the analyst consensus target of $144.20 implies 23.7% upside, and the stock has not been re-rated despite superior long-term growth
Key Concerns
- Deeply negative free cash flow of -$6.475B is the single most critical risk — this means BG is consuming cash at a massive rate, and the $600M senior notes offering (headline: 'Bunge Global SA Announces Pricing of $600 Million Senior Notes Offering') confirms the company is funding itself with debt; with only $788M cash on hand, if FCF does not normalize, the balance sheet will deteriorate rapidly and dividend/buyback sustainability is questionable
- Structural margin weakness creates fragility: net margin of 1.1% (65.4% below industry peers at 3.18%) and gross margin of 4.87% (57.9% below industry at 11.58%) mean any commodity price headwind, cost inflation, or volume shortfall could push BG into losses — the Q2 earnings miss versus consensus estimates (despite beating profit estimates on processing margins) signals that operational headwinds are real and the 17.4% next-year EPS growth projection may be optimistic given the 7.3% YoY EPS growth baseline
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
BG's fundamentals present a tale of two stories. On valuation and growth: PEG of 0.61 (industry 0.947), PE of 22.6x (industry 26.53x), P/B of 1.40x, and 5-year forward EPS growth of 17.0% (industry 8.36%) all signal undervaluation relative to growth. On profitability and cash generation: gross margin of 4.87% (industry 11.58% — 57.9% below peers), net margin of 1.1% (industry 3.18% — 65.4% below peers), ROE of 7.5% (below 15% quality threshold, though 27.5% above industry average of 5.9%), and free cash flow of -$6.475B are deeply concerning. The D/E ratio of 0.66 is 48.3% above the industry average of 0.445, and the cash position of only $788M provides minimal buffer against the massive FCF burn. Historical revenue growth of 88.3% is almost certainly non-recurring (commodity supercycle/Viterra acquisition). The YoY EPS growth of 7.3% versus the forward projection of 17.4% creates a credibility gap — analysts are projecting acceleration from a decelerating base. The operating margin of 4.617% is actually 33.2% above the industry average of 3.466%, showing BG is operationally efficient once gross profit is established, but the thin gross margin leaves almost nothing to work with. The critical question: will the Viterra integration drive FCF normalization and margin expansion? Until FCF turns positive, earnings-based metrics like PEG are unreliable. Additional metrics: PE Ratio: 22.60
News Sentiment
Bunge Global is quietly becoming one of the most interesting turnaround stories in the agricultural sector — if you're willing to be patient. The company just reported its second-quarter 2026 results, and the headline numbers tell a story of a business in transformation. Stronger performance in soybean and softseed processing segments — the exact businesses Bunge acquired when it bought Viterra — fueled meaningful growth, with adjusted earnings per share jumping significantly compared to a year ago. That's the good news. The complicated news: Bunge still missed some analyst consensus estimates, suggesting the integration isn't perfectly smooth and that margin pressure remains a real challenge. Meanwhile, the company announced pricing of a $600 million senior notes offering — essentially borrowing more money — which signals that Bunge needs external capital to fund its ambitious growth plans. That's not unusual for a company digesting a major acquisition, but it does add to the debt load. Industry observers are watching closely: year-over-year comparisons will reveal whether Bunge's core agribusiness operations are genuinely growing or just benefiting from one-time acquisition effects. The company has also been flagged as one of three AgTech and food innovation stocks worth watching as the industry evolves. Bottom line for everyday investors: Bunge is a big, complex commodity business making a big bet on processing margins. The bet is showing early signs of paying off — but the company is still burning cash and borrowing to get there.
Risk Assessment
PRIMARY RISK: The -$6.475B FCF burn is existential if it persists. The $600M senior notes offering adds to an already elevated D/E of 0.66 (48.3% above industry). If commodity margins compress or the Viterra integration disappoints, BG could face a balance sheet crisis with only $788M cash. SECONDARY RISK: The 17.4% next-year EPS growth projection is aggressive relative to the 7.3% YoY EPS baseline — a miss would reprice the stock sharply lower given the thin margin structure. COMMODITY RISK: With gross margins of only 4.87%, any adverse move in soybean, softseed, or grain prices directly threatens profitability. MITIGATION: The P/B of 1.40x provides a floor — the company has tangible asset value. The Viterra integration is a real catalyst. Position sizing at 2.5% of portfolio limits downside exposure. Stop-loss at $103 (approximately 11.6% below entry of $114) limits maximum loss. The 23.7% upside to analyst target provides adequate risk/reward of 2.7:1.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is BG a halal stock?
No, Bunge Global S.A. (BG) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for BG?
Bunge Global S.A. (BG) has a Plutrex AI rating of 62.5/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is BG a good investment?
According to Plutrex AI, BG has a Hold rating (62.5/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in BG?
US stocks like BG can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in BG?
Plutrex AI identifies the main risks for BG by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.